Analysis: Bitcoin Network Activity Approaching an All-Time High, Small Transactions and On-Chain Activity Drive Daily Transaction Volume Above 800,000 Transactions
BlockBeats News, June 19th, CryptoQuant data shows that Bitcoin network activity has risen to a level only about 7% below the September 2024 historical peak, and has broken above a long-term trendline for the first time since mid-2024, driven mainly by a large number of small transactions rather than traditional economic payment activity.
Bitcoin's daily transaction count in 2026 has exceeded 800,000 transactions, more than doubling from the 2025 low point and approaching the high points of the 2023 to 2025 cycle. CryptoQuant believes that this growth has structural characteristics rather than being a short-term fluctuation.
Notably, the percentage of small transactions below 0.01 BTC has risen to about 80%, significantly higher than the approximately 44% in 2023. This change is closely related to the usage of OP_RETURN nearing historical highs. CryptoQuant points out that protocols such as Runes, Ordinals, BRC-20, and data timestamp services are generating a large number of low-value transactions by writing data to the blockchain, with some transaction amounts going as low as 546 sats.
With the increase in on-chain activity, the number of transactions stuck in the Bitcoin mempool has risen to around 128,000 transactions, the highest level since February 2025. While still below the extreme congestion levels of September 2023 and November 2024, the report suggests that non-financial transactions are increasingly occupying more of Bitcoin's network throughput. If this trend continues, it could drive up transaction fees for economically sensitive transactions requiring higher timeliness.
Meanwhile, the rise in on-chain activity contrasts with fund flows. On June 1st, Bitcoin and Ethereum spot funds combined saw a net outflow of over $528 million. However, institutional investors still consider ETF flows as the core driver of this cycle and maintain the benchmark expectation of Bitcoin reaching $150,000 by the end of the year.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The Bank of England's most hawkish official: The labor market is "stationary" rather than loose, and inflation is deeply entrenched.
The Bank of England hawkish official Mann stated that the labor market is "static" rather than loose, and warned that inflation is deeply entrenched; rising fuel and energy prices may cause inflation to "significantly exceed 4%" early next year.
BUZZ - Bank of America gives Diodes a "Buy" rating, driving its stock price up
October 6 - Semiconductor product manufacturer Diodes (DIOD.O) saw its stock price rise 3.38% in pre-market trading to $107.64. BofA has initiated coverage of DIOD with a “Buy” rating and a price target of $135, implying about 30% upside from the previous closing price. According to the report, DIOD holds a favorable position in the automotive, industrial, and AI data center semiconductor markets, positioning it to expand its market share. The increasing use of semiconductors in automobiles and growing demand for AI infrastructure are expected to drive the company’s long-term growth. The firm anticipates that DIOD’s AI data center business—which currently accounts for about 12% of total revenue—could triple by 2030. As of the previous trading day’s close, the stock’s year-to-date growth has already more than doubled. (For the convenience of non-English speakers, Reuters provides automated translations of its reports into several other languages. Automated translations may contain errors or lack context and are provided solely for the convenience of readers. Reuters accepts no liability for any damages or losses resulting from the use of automated translation features.)
BUZZ-BridgeBio shares rise as FDA initiates priority review for dwarfism drug
On October 6th, shares of pharmaceutical company BridgeBio Pharma (BBIO.O) rose 2.5% in pre-market trading to $67.80. The company announced that the U.S. Food and Drug Administration (FDA) has granted priority review to its application seeking approval for the investigational oral drug infigratinib for the treatment of children with achondroplasia, the most common type of dwarfism. The FDA has set a target decision date of February 4, 2027. The application is based on a late-stage clinical trial that met both primary and key secondary endpoints; children treated with infigratinib experienced an adjusted annual growth velocity 1.74 centimeters greater than those given placebo. The drug also improved arm span and body proportions in children under eight years old. No serious adverse events or discontinuations related to the drug were reported. BridgeBio plans to apply for European approval in the fourth quarter of 2026. As of the close of the previous trading day, BBIO shares are down 13.5% year-to-date. (For the convenience of non-English speakers, Reuters has automated this report into several other languages. Because automated translation may contain errors or lack required context, Reuters does not guarantee the accuracy of automated translation, which is provided for readers’ convenience only. Reuters accepts no liability for any damages or losses arising from the use of automated translation.)
Google (GOOGL.US) spends $4.3 billions on electricity, securing 3,590 megawatts of long-term energy from Constellation Energy (CEG.US).
Google has signed a 3,590 MW power purchase agreement with Constellation Energy, with a quarter of the electricity coming from nuclear power, involving an investment of $4.3 billion.
Crypto prices
More
